Sign in to follow
Search Results

0 results for 'Eli Lilly'

You can use to get even better search results
June 14, 2022 | Litigation Daily

An Early-Week Batch of Litigator of the Week Shout Outs

With two weeks' worth of wins under consideration in this cycle of Litigator of the Week, we're giving a little extra shine to a worthy batch of shout outs.
5 minute read
June 07, 2022 | Law.com

State Supreme Court Sides With Eli Lilly, Rejecting Pro Se Litigant's Advertising Exception in Suit Over Cialis

The court ruled "the policies underpinning the learned intermediary doctrine remain true today."
5 minute read
June 07, 2022 | Daily Business Review

Pharma Company Sues to Block Blockchain Medical Platform From Using 'LY' for Cryptocurrency

This lawsuit was surfaced on Law.com Radar. Read the complaint here.
1 minute read
April 18, 2022 | National Law Journal

With Billions at Stake, Supreme Court Dips Its Toes Into Biologic Drug Patents

The justices have asked for the solicitor general's views on a cert petition by Amgen in a case that could reinterpret patent law's Section 112 and the law of enablement.
5 minute read
March 22, 2022 | The Legal Intelligencer

The Benefits, Consequences and Pitfalls of Terminal Disclaimers

A terminal disclaimer—a seemingly simple document that shortens a patent's life by declaring that it expires upon the expiration of another commonly owned patent—is replete with technical and substantive traps for the unwary and far-reaching consequences during both prosecution and enforcement of U.S. patents.
9 minute read
Law Journal Press | Digital Book America Invents Act (AIA) Handbook: A Guide to the Patent Law Reform of 2011, The, 2015 Edition Authors: Mary Anthony Merchant View this Book

View more book results for the query "Eli Lilly"

March 16, 2022 | Law.com

Federal Judge Allows Teva's Migraine Med Patent Lawsuit to Proceed Against Eli Lilly

Teva argues that Eli Lilly induced infringement of two of Teva's patents that protect the methods for administering the drug for the treatment of "refractory" migraines, or for patients who failed on at least two prior migraine preventative treatments.
4 minute read
February 02, 2022 | New York Law Journal

Federal Circuit Underscores Importance of Written Description Requirement

'Biogen Int'l GMBH v. Mylan Pharms.' highlights the importance of considering invalidity under the written description requirement as a potential defense in litigation—particularly in ANDA cases, in which therapeutic efficacy for specific conditions, and drugs dosage amounts, may be at issue—and for patent applicants to remain mindful of written description pitfalls throughout patent prosecution.
8 minute read
January 26, 2022 | Daily Business Review

DeSantis Blasts FDA For Halting Drugs Ineffective on Omicron

The FDA says omicron is responsible for more than 99% of U.S. infections, making it "highly unlikely" that the antibodies would be effective for people seeking treatment.
4 minute read
December 23, 2021 | Litigation Daily

Run It Back! One Last Look at the 2021 Litigators of the Week

Here's one last 'huzzah!' for this year's winners.
20 minute read
November 12, 2021 | Daily Business Review

Health-Care Giant J&J to Split Into Drug, Consumer Companies

Johnson & Johnson is following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.
6 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now